EREG and cancer: In the MI group, we detected significant interactions between macro-C3-SPP1 and MHC-II+ cancer cells via the EREG/ERBB4 axis (Figure 9D, S10D), which activates downstream MEK/ERK and PI3K/AKT signalling pathways, promoting cell proliferation and survival 49.